Perspective Therapeutics, Inc. ·

CATX 8-K 2026-10-01

Perspective Therapeutics, Inc. (CATX) 8-K dated 2026-10-01 — accession 0001193125-26-410663. This URL is the filing, not the CATX hub.

Perspective Therapeutics, Inc. (CATX) is a medical devices company listed on US.

Perspective Therapeutics, Inc. filed a 8-K on 2026-10-01. Accession 0001193125-26-410663.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CATX revenue for 2023-12-31 was $1.4M. Net income was -$46.5M. CATX currently screens at market cap $280.6M.

Not investment advice. The CATX SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr